Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists

Autor: Mandawat, Aditya *, Fiskus, Warren *, Buckley, Kathleen M., Robbins, Kelly, Rao, Rekha, Balusu, Ramesh, Navenot, Jean-Marc, Wang, Zi-Xuan, Ustun, Celalettin, Chong, Daniel G., Atadja, Peter, Fujii, Nobutaka, Peiper, Stephen C., Bhalla, Kapil
Zdroj: In Blood 9 December 2010 116(24):5306-5315
Databáze: ScienceDirect